Related Experiment Videos
[Immuno-modulating properties of a macrolide antibiotic "Z-factor"]
V S Suskova1, V I Emets, S I Suskov
1Research Institute of Transplantology and Artificial Organs, Ministry of Public Health of the Russian Federation, ZAO Veropharm, Moscow.
Summary
Zi-Factor, an azithromycin formulation, modulates neutrophil function by increasing oxidase activity. Its immunomodulatory effects on oxidative metabolism depend on the initial state of the phagocyte system.
Area of Science:
- Immunology
- Pharmacology
- Microbiology
Background:
- Zi-Factor (ZF) is a Russian-made azithromycin formulation.
- Neutrophils play a critical role in innate immunity and host defense.
- Understanding the immunomodulatory effects of antibiotics is crucial for optimizing treatment strategies.
Purpose of the Study:
- To investigate the in vitro effects of Zi-Factor on neutrophil functional activity.
- To determine the impact of Zi-Factor on the production of immune mediators.
- To assess the dose-dependent immunomodulatory action of Zi-Factor.
Main Methods:
- In vitro study of neutrophil functional activity.
- Measurement of neutrophil oxidase activity and myeloperoxidase activity.
- Assessment of intracellular oxidative metabolism in phagocytes.
Main Results:
- Zi-Factor (50 mcg/ml) directly modulated neutrophil oxidase activity, increasing active oxygen production.
- Myeloperoxidase activity was elevated by Zi-Factor at therapeutic concentrations.
- The immunomodulatory effect was dependent on the initial state of the phagocyte system, showing efficacy in both exhausted and activated states.
Conclusions:
- Zi-Factor exhibits direct immunomodulatory effects on neutrophils in vitro.
- Its efficacy in modulating oxidative metabolism is context-dependent on the phagocyte system's initial status.
- Combining Zi-Factor with immunomodulating therapy may be beneficial for patients with exhausted neutrophil oxidase systems.